Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

14.66 -0.15 (-1.01%)
Streaming Delayed Price Updated: 2:02 PM EDT, Sep 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch + Lomb Corporation Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
Expert Ratings for Bausch & Lomb
Within the last quarter, Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022
Upgrades 
Via Benzinga
From Corporate Raider To Activist Investor: Here Are Three High-Yielding Stocks Carl Icahn Favors
Formerly known as a "corporate raider," Carl Icahn is the founder and controlling shareholder of Icahn Enterprises, which is a large holding company with well diversified positions. 
Via Benzinga
Expert Ratings for Bausch & Lomb
  Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter: 
Via Benzinga
'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst
 
Via Benzinga
Expert Ratings for Bausch & Lomb
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter: 
Via Benzinga
IPO Market Posts Slowest Quarter Since Great Recession
IPOs in the second quarter plunged to the lowest level since the Great Recession in 2009, led by health care and technology. 
Via Investor's Business Daily
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision
Although Bausch Health promises to fight back against an unfavorable patent protection ruling, BHC stock is still hurting. 
Via InvestorPlace
Bausch Health (BHC) Stock Plunges 50% on Patent News
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 108 companies set new 52-week lows. 
Via Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022
Upgrades 
Via Benzinga
7 Ways to Prepare for a Recession: An Investor’s Guide
There are plenty of ways to prepare for a recession. Here are seven ways you can make sure you're ready for whatever comes next. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022
Upgrades 
Via Benzinga
2 Cheap Stocks Trading at “Deal of the Century” Prices
Simple value metrics are provenly bad at generating consistent returns, but that doesn't mean there aren't opportunities to be found. 
Via InvestorPlace
Expert Ratings for Bausch & Lomb
Over the past 3 months, 7 analysts have published their opinion on Bausch & Lomb (NYSE:BLCO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
3 Value Stocks That Could 2x in a Recession
It might be tempting to say that valuation metrics are no longer useful for certain kinds of value stocks, but you need to adjust your focus. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022
Upgrades 
Via Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022
Upgrades 
Via Benzinga
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022. 
Via InvestorPlace
RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow
RBC Capital Markets expects Bausch Health Companies Inc (NYSE: BHC) Q1 FY22 revenue of $2.02 billion (previous $2.04 billion; consensus $2.05 billion) and adjusted EBITDA of $799 million (previous $816... 
Via Benzinga
Opening Day: Bausch + Lomb Pops In Public Debut
Shares of Bausch + Lomb rose over 11% to end its first trading day at $20. This was the second biggest IPO of the year. Bausch + Lomb opened at $18.50 after having priced its initial public offering at... 
Via Talk Markets
BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today
Here's what investors in Bausch + Lomb may want to know about the highly anticipated BLCO stock IPO, which took place today. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.